readthroughSign in
CompanyIVAIVEVFNasdaq, OTCDaix, I0

Inventiva S.A.

Inventiva develops lanifibranor, a pan-PPAR agonist small molecule in Phase 3 trials for metabolic dysfunction-associated steatohepatitis.

8-KNov 12Latest SEC filing
Nov 12Latest story